Boulanger, Marie-Chloé

Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease

Coté, N., Mahmut, A., Bosse, Y., Couture, C., Pagé, S., Trahan, S., Boulanger, M.-C., Fournier, D., Pibarot, P., & Mathieu, P. (2013) · Inflammation

Cardiac Valve Diseases and TreatmentsStreptococcal Infections and Treatments

Cited by 218

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease

El Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology

Cardiac Valve Diseases and TreatmentsAdenosine and Purinergic Signaling

Cited by 150

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis

Thériault, S., Gaudreault, N., Lamontagne, M., Rosa, M., Boulanger, M.-C., Messika-Zeitoun, D., Clavel, M.-A., Capoulade, R., Dagenais, F., Pibarot, P., et al. (2018) · Nature Communications

Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 135

Innate and Adaptive Immunity in Calcific Aortic Valve Disease

Mathieu, P., Bouchareb, R., & Boulanger, M.-C. (2015) · Journal of Immunology Research

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 121

Basic Mechanisms of Calcific Aortic Valve Disease

Mathieu, P., & Boulanger, M.-C. (2014) · Canadian Journal of Cardiology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 107

The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives

Mathieu, P., Bossé, Y., Huggins, G. S., Corte, A. D., Pibarot, P., Michelena, H. I., Limongelli, G., Boulanger, M., Evangelista, A., Bédard, E., et al. (2015) · The Journal of Pathology: Clinical Research

Aortic Disease and Treatment ApproachesCardiac Valve Diseases and Treatments

Cited by 76

Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor

Mahmut, A., Boulanger, M.-C., Bouchareb, R., Hadji, F., & Mathieu, P. (2015) · Cardiovascular Research

Adenosine and Purinergic SignalingCardiac Valve Diseases and Treatments

Cited by 48

Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling

Mahmut, A., Boulanger, M., Fournier, D., Couture, C., Trahan, S., Pagé, S., Arsenault, B., Després, J., Pibarot, P., & Mathieu, P. (2013) · European Journal of Clinical Investigation

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 31

Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesis

Chignon, A., Rosa, M., Boulanger, M.-C., Argaud, D., Devillers, R., Bon-Baret, V., Mkannez, G., Li, Z., Rufiange, A., Gaudreault, N., et al. (2021) · iScience

Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 18